skip to Main Content
blank

Excelsoft Technologies IPO Allotment LIVE: GMP drops, allotment out. How to check status online on BSE, MUFG Intime | Stock Market News

Excelsoft Technologies IPO Allotment LIVE: Excelsoft Technologies IPO allotment status has been finalised. The public issue of SaaS solutions and services provider Excelsoft Technologies Ltd was open from November 19 to 21, and Excelsoft Technologies IPO allotment date was 24 November 2025. The ipo listing date is November 26 and the equity shares of the company will be listed on both the stock exchanges, BSE and NSE.

Excelsoft Technologies IPO allotment status is out. The company will now credit the equity shares into the demat accounts of eligible allotment holders on November 25 and initiate refunds to unsuccessful bidders on the same day.

blank

Open A/C With Motilal Oswal

Upto 4X Margin Funding in Equity

Free Account Opening

Investors can check Excelsoft Technologies IPO allotment status online through the websites of BSE and NSE, along with the official portal of the IPO registrar. MUFG Intime India Pvt. Ltd. is the Excelsoft Technologies IPO registrar.

Excelsoft Technologies ipo gmp Today

Excelsoft Technologies shares are commanding a modest grey market premium (GMP). Excelsoft Technologies IPO GMP today has fallen to 6 per share, market experts said. Excelsoft Technologies IPO GMP today signals that the estimated listing price of the equity shares would be 126 apiece, which is at a premium of 5% to the IPO price of 120 per share.

Stay tuned to our Excelsoft Technologies IPO Allotment Live Blog for the latest updates.

Related Articles

The opinions and investment advice provided by experts on ipogmp.org are solely their own and do not reflect the views of the website or its management. Ipogmp.org recommends that users consult with certified professionals before making any investment decisions. *Please note that advisory services mentioned on Ipogmp.org are not currently operational and are proposed services awaiting SEBI registration.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top